Lucid Diagnostics receives Nasdaq notice for failing minimum bid price requirement
LUCD•Lucid Diagnostics received a Nasdaq notice on October 12, 2026, after its stock closed below $1 for 30 consecutive business days. It has until April 12, 2027, to regain compliance; trading continues uninterrupted in the meantime.
1. Nasdaq compliance period
Lucid Diagnostics said it received a noncompliance notice for breaching Nasdaq’s $1 minimum bid price requirement. To regain compliance, the stock must close at or above $1 for 10 consecutive business days before the April 12, 2027 deadline. An additional 180-day extension may be available; otherwise, delisting could follow if eligibility requirements are unmet or Nasdaq considers remediation unlikely. The notice has no immediate effect on the listing, and trading continues under LUCD.
